EUCTR2004-002006-30-GB进行中（未招募）不适用
Triple therapy in early active rheumatoid arthritis - TEAR
orth Glasgow NHS Trust0 个研究点目标入组 96 人开始时间: 2005年2月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Rheumatoid arthritis
- •Active disease (measured using the validated disease activity score)
- •Disease duration < 5 years
- •Age 18-80 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous use of disease modifying drugs (other than hydroxychloroquine)
- •Creatinine > 160
- •White cell count <4
- •Platelet count < 150
- •Pregnancy, planned pregnancy, unwillingness to use contraception
研究者
相似试验
已完成
不适用
Active management of rheumatoid arthritis (RA)ISRCTN78142229Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)100
已完成
不适用
BeSt, BehandelStrategieën in Reumatoïde Artritis.NL-OMON24149Dutch College of Health Insurance Companies508
招募中
不适用
TApering strategies in Rheumatoid Arthritis remission induced by anti-TNF&classic DMARDs. Should we taper the classic DMARD or anti-TNF first?rheumatoid arthritisrheumatism10023213NL-OMON41388Erasmus MC, Universitair Medisch Centrum Rotterdam355
已完成
不适用
Combination anti-rheumatic drugs in early rheumatoid arthritisOrthopaedics, rheumatologyMusculoskeletal DiseasesRheumatoid arthritisISRCTN32484878Medical Research Council (MRC) (UK)468
已完成
不适用
Treatment strategies for Rheumatoid Arthritis (BeSt - BehandelStrategieën in Reumatoïde Artritis)Musculoskeletal DiseasesArthropathiesRheumatoid arthritisISRCTN32675862eiden University Medical Centre (LUMC) (Netherlands)508